Literature DB >> 29088434

Reply to Aguiar and Stollenwerk.

Yang Yang1, Ya Meng1, M Elizabeth Halloran2,3, Ira M Longini1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29088434      PMCID： PMC5848237          DOI： 10.1093/cid/cix883

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine.

Authors:  Annelies Wilder-Smith; Kirsten S Vannice; Joachim Hombach; Jeremy Farrar; Terry Nolan
Journal:  J Infect Dis       Date:  2016-08-05       Impact factor: 5.226

2.  ADE and dengue vaccination.

Authors:  Ruth Aralí Martínez-Vega; Gabriel Carrasquila; Expedito Luna; José Ramos-Castañeda
Journal:  Vaccine       Date:  2017-06-13       Impact factor: 3.641

3.  Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent Data.

Authors:  Maíra Aguiar; Nico Stollenwerk
Journal:  Clin Infect Dis       Date:  2018-02-01       Impact factor: 9.079

4.  Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.

Authors:  Yang Yang; Ya Meng; M Elizabeth Halloran; Ira M Longini
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

5.  Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

Authors:  Neil M Ferguson; Isabel Rodríguez-Barraquer; Ilaria Dorigatti; Luis Mier-Y-Teran-Romero; Daniel J Laydon; Derek A T Cummings
Journal:  Science       Date:  2016-09-02       Impact factor: 47.728
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.